Ultrasound analysis methods during HIFU prostate cancer treatment
Part of Cancer, Kidney & urinary clinical trials.
This study compares different ways to analyze ultrasound images in real time while treating localized prostate cancer with HIFU (a focused ultrasound treatment). It aims to improve how safely and accurately the treatment is monitored.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must agree after being fully informed and sign the study consent form.
- You are a man age 50 or older.
- Your PSA blood test is 15 or lower (a measure related to prostate cancer).
- You have localized prostate cancer (stage T1 or T2) and Gleason score 7 or lower.
- You are scheduled for a focal or partial HIFU treatment plan decided as appropriate by the team.
- You can provide a readable pre-treatment prostate MRI done within the last 180 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a focused ultrasound treatment for benign prostatic hyperplasia (BPH), which is a non-cancerous enlargement of the prostate. It aims to see if HIFU can safely relieve symptoms like weak urine flow and frequent urination.
This trial compares focal HIFU (a targeted heating treatment inside the prostate) with prostate surgery, looking at overall cost and quality of life. It may help people with certain early, limited prostate cancers understand which option fits best for them.
This observational study looks at outcomes after people choose HIFU (high-intensity focused ultrasound) to treat only a targeted area of the prostate. It may help doctors better understand how well HIFU works and what follow-up imaging or testing shows over time.
This trial studies a focused ultrasound treatment called HIFU for prostate cancer that appears limited to the early stages. It aims to treat cancer within the prostate while avoiding treatment spread to lymph nodes or distant organs.
This trial studies whether a high-intensity focused ultrasound treatment can help people with localized prostate cancer while still avoiding traditional full-dose treatment for some patients. It may be an option for certain intermediate-risk cases where the cancer is confined to the prostate.
This study collects data on men with early, low-risk prostate cancer who choose to have a targeted ultrasound treatment called HIFU (High-Intensity Focused Ultrasound). It looks at how well this treatment works and how men recover.
Hear when a new Prostatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.